The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
NeoGenomics Inc. | COM NEW | 64049M209 | 13,252 | 1,539,113 | SH | SOLE | 1,539,113 | 0 | 0 | ||
Horizon Therapeutics Public Limited Company | SHS | G46188101 | 33,578 | 542,543 | SH | SOLE | 542,543 | 0 | 0 | ||
Vericel Corporation | COM | 92346J108 | 12,829 | 552,963 | SH | SOLE | 552,963 | 0 | 0 | ||
Five9, Inc. | COM | 338307101 | 13,135 | 175,178 | SH | SOLE | 175,178 | 0 | 0 | ||
ISHARES TR | CORE 1 5 YR USD | 46432F859 | 103 | 2,228 | SH | SOLE | 2,228 | 0 | 0 | ||
ISHARES TR | CORE S&P500 ETF | 464287200 | 84 | 234 | SH | SOLE | 234 | 0 | 0 | ||
ISHARES TR | CORE MSCI EAFE | 46432F842 | 20,537 | 389,922 | SH | SOLE | 389,922 | 0 | 0 | ||
ISHARES TR | CORE INTL AGGR | 46435G672 | 42 | 862 | SH | SOLE | 862 | 0 | 0 | ||
ISHARES TR | CR 5 10 YR ETF | 46435G417 | 35 | 834 | SH | SOLE | 834 | 0 | 0 | ||
ISHARES TR | CORE S&P MCP ETF | 464287507 | 27 | 122 | SH | SOLE | 122 | 0 | 0 | ||
ISHARES TR | CORE MSCI EMKT | 46434G103 | 13,072 | 304,145 | SH | SOLE | 304,145 | 0 | 0 | ||
ISHARES TR | CORE S&P SCP ETF | 464287804 | 15 | 169 | SH | SOLE | 169 | 0 | 0 | ||
JAMF HOLDING CORP | COM | 47074L105 | 13,815 | 623,443 | SH | SOLE | 623,443 | 0 | 0 | ||
MITEK SYS INC | COM NEW | 606710200 | 2,329 | 254,255 | SH | SOLE | 254,255 | 0 | 0 |